PCI and ACS: Where do Vorapaxar vorapaxar and bivalirudin fit in?

Name: PCI and ACS: Where do Vorapaxar vorapaxar and bivalirudin fit in?
Uploaded: 2015-06-01T00:00:00+00:00
Description: Naveen L. Pereira, M.D., and Gurpreet S. Sandhu, M.D., Ph.D., discuss adjunctive pharmacotherapy and coronary artery disease.

Naveen L. Pereira, M.D., assistant professor of medicine and pharmacology, and Gurpreet S. Sandhu, M.D., Ph.D., director of the Cardiac Catheterization Laboratory at Mayo Clinic's campus in Rochester, Minnesota, discuss adjunctive pharmacotherapy and coronary artery disease, with an emphasis on anticoagulation and antiplatelet drugs.

Published

June 1, 2015

Created by

Related Videos

Lipid management update: Where does inclisiran fit in?

Adding inclisiran to the cholesterol-lowering arsenal. Mayo Clinic cardiologists Christopher V. DeSimone, M.D., Ph.D., and Stephen Kopecky, M.D., discuss efficacy, when to use it and how best to increase statin therapy adherence in patients.

Responding to successive waves of the coronavirus in a Singapore academic medical center — Mayo Clinic Cardiovascular Grand Rounds COVID-19 Series — Part 3

Paul Ananth Tambyah, M.D., National University Hospital, Singapore, discusses patient presentations of COVID-19 in Singapore and evolving care options for treating patients.

Mayo Clinic's approach to the arterial switch operation

Elizabeth H. Stephens, M.D., Ph.D., a Mayo Clinic congenital heart surgeon, demonstrates her technique in the arterial switch operation

Lessons from China on critical care considerations and staff safety during COVID-19 - Mayo Clinic Cardiovascular Grand Rounds COVID-19 Series — Part 1

CV Grand Rounds video presents two guest faculty from China who share their experiences in treating critical patients with COVID-19.

Behavior modification in treatment of atrial fibrillation

Mayo Clinic electrophysiologist Suraj Kapa, M.D., and preventive cardiologist Francisco Lopez-Jimenez, M.D., discuss the use of behavioral modifications for treatment of atrial fibrillation.

CV Grand Rounds — The Fontan operation: Unanticipated consequences

Mayo Clinic cardiologist, Alexander C. Egbe, M.B.B.S., discusses the unanticipated consequences of the Fontan operation. Fontan is a surgical procedure used in patients who are born with single ventricle physiology.

How and when to treat PVCs

Mayo Clinic electrophysiologist, Paul A. Friedman, M.D., reviews when premature ventricular complexes (PVCs) require further evaluation, the type of evaluation required and when treatment is necessary.